Adverse drug reactions of Intermittent chemotherapy compared to daily regimen in Sudanese patients with pulmonary Tuberculosis

Salih, Mutasim S. M

dc.contributor.author	Salih, Mutasim S. M
dc.date.accessioned	2016-06-14T10:09:08Z
dc.date.available	2016-06-14T10:09:08Z
dc.date.issued	2012-03-01
dc.identifier.uri	http://hdl.handle.net/123456789/9
dc.description.abstract	The World Health Organization (WHO) declared Tuberculosis a global health emergency in 1993 as it remains a major cause of mortality in developing countries. The World Health Organization's Directly Observed Treatment Short course (DOTs) strategy achieve 87% success rate in the areas where it is implemented, usually with five drugs, lasts for 6months. Till 1998 Sudan was classified as one of the slowly moving countries in implementation of the DOTS strategy and making no progress against tuberculosis.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Sudan JMS	en_US
dc.relation.ispartofseries	Vol. 7;No.1
dc.subject	Research Subject Categories::MEDICINE	en_US
dc.title	Adverse drug reactions of Intermittent chemotherapy compared to daily regimen in Sudanese patients with pulmonary Tuberculosis	en_US
dc.title.alternative	Adverse drug reactions of Intermittent chemotherapy in pulmonary TB	en_US
dc.type	Article	en_US